Edison Nation Medical and the Mount Sinai Health System Collaborate to Evaluate and Commercialize Medical Device and Consumer Related Healthcare Inventions

December 1, 2014 – Edison Nation Medical, the premier marketplace for healthcare and medical device innovation, today announced a partnership with the Mount Sinai Health System, one of the country’s largest integrated health care networks providing exceptional medical care and world-class medical research. Edison Nation Medical will work closely with Mount Sinai Innovation Partners (MSIP), Mount Sinai’s technology development and commercialization group, to prioritize and bring to market medical device and consumer related healthcare inventions from the Mount Sinai community.

This collaboration highlights the significance of public-private partnerships within the new healthcare landscape to deliver innovations to patients. Traditional early stage technology commercialization efforts at large institutions rely on seasoned research faculty to deliver novel ideas and concepts that will have a positive impact on public health. Through this partnership, Mount Sinai and Edison Nation Medical look to expand innovation beyond the laboratory by encouraging constituents from across the health system including primary care and clinical service personnel to share new inventions.

“MSIP is excited to introduce Edison Nation Medical to our institution,” stated Erik Lium, PhD, Vice President, Mount Sinai Health System and Executive Director MSIP. “It is a great opportunity to engage with additional stakeholders outside of the traditional research environment who contribute to our innovative culture and have a positive impact on the future of healthcare.”

Since its inception, Edison Nation Medical has worked with individuals, early stage start-ups, and institutions to capture innovation and improve healthcare globally. Serving as a healthcare innovation marketplace, Edison Nation Medical matches inventors, entrepreneurs, and universities with potential manufacturing partners who desire access to a steady stream of fully-vetted innovations. Under the terms of this agreement, MSIP will submit appropriate inventions in the clinical tool and medical device spaces to Edison Nation Medical, adding value to MSIP’s innovation evaluation, prioritization and development processes.

“Leading research institutions like Mount Sinai generate a significant volume of high-quality innovation,” said Robert Grajewski, President of Edison Nation Medical. “At Edison Nation Medical, we have the infrastructure and expertise to handle innovation at scale, and we’re thrilled to work with MSIP to help them efficiently translate devices and consumer related healthcare products from concept to marketplace.”

About Edison Nation Medical
Edison Nation Medical is a healthcare innovation marketplace with deep expertise in open innovation, product development, and healthcare. Born out of collaboration with Carolinas HealthCare System (the second largest public health system in the United States), Edison Nation Medical’s mission is to break down the barriers to healthcare innovation. We make this a reality by providing a clear and easy pathway through our open innovation platform for anyone — physicians, nurses, entrepreneurs, even patients and caregivers — to submit a medical invention idea for full evaluation and potential commercialization. Edison Nation Medical innovation headquarters is in Charlotte, NC with satellite offices in San Francisco and New York City. For more information, please visitwww.EdisonNationMedical.com or find Edison Nation Medical on Twitter, Facebook, and LinkedIn.

About Mount Sinai Innovation Partners
Mount Sinai Innovation Partners (MSIP) facilitates the real-world application and commercialization of Mount Sinai discoveries and the development of research partnerships with industry. MSIP is responsible for the full spectrum of commercialization activities required to bring the Icahn School of Medicine’s inventions to life. These activities include evaluating, patenting, marketing, and licensing new technologies, while also engaging commercial and non-profit relationships for sponsored research, material transfer, and confidentiality. For more information, visit www.ip.mountsinai.org.

About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care. The System includes approximately 6,600 primary and specialty care physicians, 12-minority-owned free-standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City,Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report. For more information, visit https://www.mountsinai.org, or find Mount Sinai on Facebook, Twitter and YouTube.